Skip to Main Content

Paper Details

Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib.
NPJ Breast Cancer
9
2022
Author NameAffiliation
James HicksConvergent Science Institute in Cancer (CSI-Cancer), Michelson Center for Convergent Bioscience, University of Southern California,1002 Childs Way
Peter KuhnConvergent Science Institute in Cancer (CSI-Cancer), Michelson Center for Convergent Bioscience, University of Southern California,1002 Childs Way
  • 1 - 2

Datasets